Content of PD-1+ and PD-L1+ peripheral blood lymphocytes in individuals with pollen sensitization before and after allergen-specific immunotherapy
- 作者: Barkovskaya M.1, Sevastyanov P.2, Demina D.1, Kozlov V.1
-
隶属关系:
- Research Institute of Fundamental and Clinical Immunology
- Novosibirsk National Research State University
- 期: 卷 25, 编号 4 (2022)
- 页面: 385-392
- 栏目: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/120053
- DOI: https://doi.org/10.46235/1028-7221-1192-COP
- ID: 120053
如何引用文章
全文:
详细
The available data on the contribution of the PD-1 and its ligands to immunoregulatory processes suggest their involvement into development of tolerance during immunotherapy. Currently, allergen-specific immunotherapy (ASIT) is the single treatment option that can influence the outcome of allergic diseases. Our purpose was to evaluate the PD-1/PD-L1 expression on the immune cells in patients with confirmed sensitization to plant pollen allergens in comparison with healthy controls before and after ASIT. The patients with bronchial asthma (BA) (n = 5, age 33.8±2.7), allergic rhinitis (AR) (n = 7, age 31.6±2.8), and healthy donors (n = 12, age 32.8±1.8) were included. Venous blood samples were obtained from the patients three times: before starting ASIT, upon completion of the ASIT course, and during the period of seasonal exacerbation. In patients with AR, the number of B lymphocytes was decreased, and the expression of PD-L1 by B lymphocytes increased after ASIT in comparison with donor parameters. At the same time, B lymphocyte counts were increased in BA patients before ASIT and returned to normal after ASIT. In AR, the CD8+PD-1+T lymphocyte count was reduced before ASIT, however, returning to normal values after ASIT was completed. Meanwhile, the reduced number of CD4+PD-1+T lymphocytes returned to normal only during the pollination season following ASIT. In BA patients, both before or after ASIT, PD-1 and PD-L1 expression on CD4+ and CD8+T lymphocytes did not differ from the donor parameters. The PD-1 expression in the T regulatory cells (Tregs) was decreased comparing with donors before ASIT in BA, and in the patients with AR, both before and after treatment. It was shown earlier that low PD-1 expression in the circulating CD4+ T cells is associated with high specific IgE concentrations. Thus, low PD-1 levels on CD4+ and CD8+T lymphocytes and regulatory T cells may indicate their functional disorders in allergic pathology. In summary, our results show a regulatory role of PD-1/PD-L1 axis in the immune response during ASIT and reflect differences in pathogenesis of allergic disorders, which are associated with imbalance of the cell activation and suppression. Further studies are required to establish the role of PD-1/PD-L1 interactions in the process of ASIT-induced modification of allergic responses.
作者简介
M. Barkovskaya
Research Institute of Fundamental and Clinical Immunology
编辑信件的主要联系方式.
Email: margaritabarkovskaya@gmail.com
PhD (Medicine), Research Associate, Laboratory of Clinical Immunopathology
俄罗斯联邦, Novosibirsk
P. Sevastyanov
Novosibirsk National Research State University
Email: margaritabarkovskaya@gmail.com
Student
俄罗斯联邦, NovosibirskD. Demina
Research Institute of Fundamental and Clinical Immunology
Email: margaritabarkovskaya@gmail.com
PhD (Medicine), Allergologist-Immunologist, Head, Department of Allegology
俄罗斯联邦, NovosibirskV. Kozlov
Research Institute of Fundamental and Clinical Immunology
Email: margaritabarkovskaya@gmail.com
PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Head, Laboratory of Clinical Immunopathology, Scientific Director
俄罗斯联邦, Novosibirsk参考
- Авдеев С.Н., Ненашева Н.М., Жуденков К.В., Петраковская В.А., Изюмова Г.В. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации // Пульмонология, 2018. Т. 28, № 3. С. 341-358. [Avdeev S.N., Nenasheva N.M., Zhudenkov K.V., Petrakovskaya V.A., Izyumova G.V. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya = Pulmonologiya, 2018, Vol. 28, no. 3, рр. 341-358. (In Russ.)]
- Балаболкин И.И., Порядин Г.В., Рябинина З.В., Ларькова И.А. Динамика экспрессии поверхностных маркеров лимфоцитов детей с атопической бронхиальной астмой под влиянием аллергенспецифической иммунотерапии // Иммунопатология, аллергология, инфектология. 2010. № 2. С. 67-74. [Balabolkin I.I., Poryadin G.V., Ryabinina Z.V., Larkova I.A. Dynamics of expression of surface markers of lymphocytes of children with moderate atopic bronchial asthma under the influence of allergen-specific immunotherapy. Immunopatologiya, allergologiya, infektologiya = International Journal of Immunopatholody, Allergology, Infectology, 2010, no. 2, pp. 67-74. (In Russ.)]
- Попович В.И., Вильчинская Т., Кошель И.В. Современные взгляды на патофизиологию аллергического ринита // Оториноларингология. Восточная Европа, 2019. Т. 9, № 2. С. 199-212. [Popovich V.I., Wilczyńska T., Coshel I.V. Мodern approaches to pathophysiology of allergic rhinitis. Otorinolaringologiya. Vostochnaya Evropa = Otorhinolaryngology. Eastern Europe, 2019, Vol. 9, no. 2, pp. 199-212. (In Russ.)]
- Рахматуллина Н.М., Пастушенко Ю.В., Трофимова О.Р., Сибгатуллина Н.А., Ахмедзянова Д.Г., Закирова Г.Н. Современные методы аллерген-специфической иммунотерапии в лечении аллергического ринита // Казанский медицинский журнал, 2016. Т. 97, № 2. С. 288-294. [Rakhmatullina N.M., Pastushenko Yu.V., Trofimova O.R., Sibgatullina N.A., Akhmedzyanova D.G., Zakirov G.N. Modern methods of allergen-specific immunotherapy in allergic rhinitis treatment. Kazanskiy meditsinskiy zhurnal = Kazan Medical Journal, 2016, Vol. 97, no. 2, рр. 288-294. (In Russ.)]
- Скибо Ю.В., Курмаева Н.Ш., Цибулькина В.Н., Абрамова З.И. Структура основных популяций лимфоцитов у больных атопической бронхиальной астмой разной степени тяжести // Практическая медицина, 2012. Т. 9, № 65. С. 154-158. [Skibo Yu.V., Kurmaeva N.S., Tsibulkina V.N., Abramova Z.I. The structure of the main populations of lymphocytes in patients atopic asthma of varying severity. Prakticheskaya meditsina = Practical Medicine, 2012, Vol. 9, no. 65, рр. 154-158. (In Russ.)]
- Топтыгина А.П. Коингибирующие молекулы в норме и при патологии. Контрольные точки (checkpoint) иммунорегуляции. Часть 1. Роль коингибирующих молекул в нормальном иммунном ответе, при аллергии и аутоиммунных заболеваниях // Российский иммунологический журнал, 2017. Т. 20, № 4. С. 593-604. [Toptygina A.P. Co-inhibitory molecules in normal and pathological conditions. immonological checkpoints Part 1. Role of co-inhibitory molecules in normal immune response and in allergy and autoimmune diseases. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2017, Vol. 20, no. 2, рр. 593-604. (In Russ.)]
- Boonpiyathad T., Meyer N., Moniuszko M., Sokolowska M., Eljaszewicz A., Wirz O.F., Tomasiak-Lozowska M.M., Bodzenta-Lukaszyk A., Ruxrungtham K., van de Veen W. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers. Allergy, 201, Vol. 72, no. 3, pp. 407-415.
- Bratke K., Fritz L., Nokodian F., Geißler K., Garbe K., Lommatzsch M., Virchow J. C. Differential regulation of PD-1 and its ligands in allergic asthma. Clin. Exp. Allergy, 2017, Vol. 47, no. 11, pp. 1417-1425.
- Chamoto K., Al-Habsi M., Honjo T. Role of PD-1 in Immunity and diseases. Springer, Cham, 2017. 75 р.
- Morales M.A.G., Montero-Vargas J.M., Vizuet-de-Rueda J.C., Teran L.M. New Insights into the role of PD-1 and its ligands in allergic disease. Int. J. Mol. Sci., 2021, Vol. 22, no. 21, 11898. doi: 10.3390/ijms222111898.
- Shamji M.H., Kappen J.H., Akdis M., Jensen-Jarolim E., Knol E.F., Kleine-Tebbe J., Bohle B., Chaker A.M., Till S.J., Valenta R., Poulsen L.K., Calderon M.A., Demoly P., Pfaar O., Jacobsen L., Durham S.R., Schmidt-Weber C.B. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy, 2017, Vol. 72. no. 8, pp. 1156-1173.
- Siewe B., Wallace J., Rygielski S., Stapleton J.T., Martin J., Deeks S.G., Landay A. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One, 2014, Vol. 9. no. 4, e92934. doi: 10.1371/journal.pone.0092934.
- Sørensen A.E., Johnsen C.R., Dalgaard L.T., Würtzen P.A., Kristensen B., Larsen M.H., Ullum H., Søes-Petersen U., Hviid T.V.F. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy. Int. Arch. Allergy Immunol., 2013, Vol. 162, no. 3, pp. 237-252.
- Xi X., Liu J.-M., Guo J.-Y. Correlation of PD-1/PD-L1 signaling pathway with Treg/Th17 imbalance from asthmatic children. Int. Arch. Allergy Immunol., 2018, Vol. 176, no. 3-4, pp. 255-267.